Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) plat
Asepsis Announces the Grant of Canadian Patent No. 3,006,218
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021
Asepsis announces the US Patent Grant 11,058,606
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 11,058,606 for its Safe-T-Fuse™ d
Asepsis Announces the Grant of Mexico Patent MX/a/2017/012034
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated i
Asepsis Announces the Grant of U.S. Patent 10,857,299
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform,
Asepsis Announces the U.S. Patent Grant No. 10,625,026
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The
Asepsis Announces the Safe-2-Dose Integrated Dosing Container
Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need o
Asepsis Announces Australian Patent Acceptance No. 2018232988
Asepsis Medical Technologies announces the Australian Patent Acceptance No. 2018232988 for a suction and/or pressure ind
Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 15/255,725 for its Safe-T-Fuse™ d